ENTRY       D07130                      Drug
NAME        Carglumic acid (JAN/USAN/INN);
            Carbaglu (TN)
PRODUCT     CARBAGLU (Recordati Rare Diseases)
  GENERIC   CARGLUMIC ACID (Burel Pharmaceuticals)
            CARGLUMIC ACID (Eton Pharmaceuticals)
            CARGLUMIC ACID (Navinta LLC)
FORMULA     C6H10N2O5
EXACT_MASS  190.059
MOL_WEIGHT  190.154
REMARK      Same as: C05829
            Therapeutic category: 3999
            ATC code: A16AA05
            Product: D07130<JP/US>
EFFICACY    Antihyperammonemic
  DISEASE   NAGS deficiency [DS:H01032]
COMMENT     Treatment of hyperammonaemia due to N-acetylglutamate synthase (NAGS) deficiency
TARGET      CPS1 [HSA:1373] [KO:K01948]
  PATHWAY   hsa00220(1373)  Arginine biosynthesis
            hsa00250(1373)  Alanine, aspartate and glutamate metabolism
            hsa00910(1373)  Nitrogen metabolism
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             A ALIMENTARY TRACT AND METABOLISM
              A16 OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS
               A16A OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS
                A16AA Amino acids and derivatives
                 A16AA05 Carglumic acid
                  D07130  Carglumic acid (JAN/USAN/INN) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Electrolytes/Minerals/Metals/Vitamins
              Electrolyte/Mineral Replacement
               Carglumic  Acid
                D07130  Carglumic acid (JAN/USAN/INN)
            Therapeutic category of drugs in Japan [BR:br08301]
             3  Agents affecting metabolism
              39  Other agents affecting metabolism
               399  Miscellaneous
                3999  Others
                 D07130  Carglumic acid (JAN/USAN/INN)
            Target-based classification of drugs [BR:br08310]
             Enzymes
              Ligases (EC6)
               Carbamoyl-phosphate synthase
                CPS1
                 D07130  Carglumic acid (JAN/USAN/INN) &lt;JP/US&gt;
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D07130
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D07130
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D07130
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D07130
            Pharmacogenomic biomarkers [br08341.html]
             Germline mutations in genetic disorder treatments
              D07130
DBLINKS     CAS: 1188-38-1
            PubChem: 51091469
            ChEBI: 71028
            LigandBox: D07130
ATOM        13
            1   O6a O    14.9813  -16.8715
            2   C6a C    16.1938  -17.5716
            3   C1b C    17.4064  -16.8715
            4   C1b C    18.6189  -17.5716
            5   C1c C    19.8314  -16.8715
            6   C6a C    21.0440  -17.5716
            7   O6a O    22.2565  -16.8715
            8   O6a O    16.1938  -18.9715
            9   O6a O    21.0440  -18.9714
            10  N1b N    19.8314  -15.4715
            11  C5a C    18.6000  -14.7699
            12  O5a O    18.6017  -13.3698
            13  N1a N    17.4047  -15.4638
BOND        12
            1     1   2 1
            2     2   3 1
            3     3   4 1
            4     4   5 1
            5     5   6 1
            6     6   7 1
            7     2   8 2
            8     6   9 2
            9     5  10 1 #Down
            10   10  11 1
            11   11  12 2
            12   11  13 1
///
